Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging

Dementia and Geriatric Cognitive Disorders

Volumn 35, Issue 5-6, 2013, Pages 280-290

  Fukazawa, Raita ^a   Hanyu, Haruo ^a   Sato, Tomohiko ^a   Shimizu, Soichiro ^a   Koyama, Shunichi ^a   Kanetaka, Hidekazu ^a   Sakurai, Hirofumi ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Dementia; Diabetes mellitus; MRI; SPECT

Indexed keywords

APOLIPOPROTEIN E4; HEMOGLOBIN A1C; INSULIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN PERFUSION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; WORD RECOGNITION; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER PROGRAM; FUNCTIONAL NEUROIMAGING; GAMMA CAMERA; HEMOGLOBIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE SCANNER; TEMPORAL LOBE ATROPHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATROPHY; BRAIN; DIABETES COMPLICATIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84876081849     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000348407     Document Type: Article

References (40)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P: Risk of dementia in diabetes mellitus: A systemic review. Lancet Neurol 2006; 5: 64-74
2. Bonte FJ, Harris TS, Hynan LS, Bigio EH, White III CL: Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation. Clin Nucl Med 2006; 31: 376-378
3. Jobst KA, Barnetson LPD, Shepstone BJ: Accurate prediction of histopathologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and ApoE4 in medial temporal lobe dementias. Int Psychogeriatr 1998; 10: 271-302
4. Dougall NJ, Bruggink S, Ebmeier KP: Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004; 12: 554-570
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Revised. Washington, DC: American Psychiatric Association, 1987
6. The Diabetes Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
7. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260
8. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB: Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005; 65: 1863-1872
9. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554
10. Ishikawa M: Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 2004; 44: 222-223
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944
12. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572
13. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
14. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972
15. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351-356
16. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248
17. Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K: The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: A longitudinal SPECT study. J Neurol Sci 2010; 290: 96-101
18. Hanyu H, Asano T, Kogure T, Abe S, Iwamoto T, Takasaki M: Diagnosis of Alzheimer's disease using brain SPECT with three-dimensional stereotactic surface projections. Clinical Neurol (Tokyo) 2001; 41: 582-587
19. Burdette J, Minoshima S, Borght TV, Tran DD, Kuhl DE: Alzheimer disease: Improved visual interpretation of PET images by using three-dimensional stereotactic surface projections. Radiology 1996; 198: 837-843
20. Kataoka S, Paidi M, Howard BV: Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype. Clin Chem 1994; 40: 11-13
21. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, ApoE gene, and the risk for dementia and related pathologies. The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256-1262
22. Matsuzaki T, Sasaki k, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T: Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama study. Neurology 2010; 75: 764-770
23. Heitner J, Dickson D: Diabetics do not have increased Alzheimer-Type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 1997; 49: 1306-1311
24. Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, Purohit DP, Perl DP, Davidson M, Mohs RC, Haroutunian V: Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci 2005; 60: 471-475
25. Sonnen JA, Larson EB, Brickell K, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S: Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009; 66: 315-322
26. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R, Kivipelto M: Diabetes, Alzheimer disease, and vascular dementia. A population-based neuropathologic study. Neurology 2010; 75: 1195-1202
27. Umegaki H, Kawamura T, Kawano N, Umemura T, Kanai A, Sano T: Factors associated with cognitive decline in elderly diabetes. Dement Geriatr Cogn Disord Extra 2011; 1: 1-9
28. Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, Grimm KJ, Clarke WL: Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005; 228: 71-77
29. Sommerfield AJ, Deary IJ, Frier BM: Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 2004; 27: 2335-2340
30. Langan SJ, Deary IJ, Hepburn DA, Frier BM: Cumulative cognitive impairment following recurrent hypoglycemia in adult patients with insulin-Treated diabetes mellitus. Diabetologia 1991; 34: 337-344
31. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH: Cerebral function in diabetes mellitus. Diabetologia 1994; 37: 643-650
32. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53: 1937-1942
33. van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ: Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta 2009; 1792: 470-481
34. Strachan MWJ, Deary IJ, Ewing FME, Frier BM: Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20: 438-445
35. Sakurai T, Kuranaga M, Akisaki T, Takata T, Endo H, Yokono K: Differential mini-mental state examination profiles of older people with diabetes mellitus with early Alzheimer's disease. J Am Geriatr Soc 2007; 55: 955-969
36. Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S: Staging of argyrophilic grains: An age-Associated tauopathy. J Neuropath Exp Neurol 2004; 63: 911-918
37. Yamada M: Senile dementia of the neurofibrillary tangle type (tangle-only dementia): Neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 2003; 23: 311-317
38. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ: Cerebral microinfarcts: A systematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-436
39. Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, Canonico S, Paolisso G: Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 2010; 33: 2169-2174
40. Anderson RJ, Clouse RE, Freedland KE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001; 24: 1069-1078